Amphastar Pharmaceuticals Inc (AMPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AMPH? Forum Prognose

Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.28% 174.41	170.53	191.21	182.39	171.84
Cost Of Revenue	3.10% 87.92	85.28	89.27	87.23	81.74
Gross Profit	1.45% 86.49	85.25	101.94	95.17	90.10
Operating Expenses	7.61% 44.31	47.96	44.89	39.95	42.09
Benefits Costs and Expenses	3.28% 135.08	139.67	143.53	132.15	123.96
Costs And Expenses	3.28% 135.08	139.67	143.53	132.15	123.96
Operating Income/Loss	13.12% 42.18	37.29	57.05	55.22	48.01
Nonoperating Income/Loss	55.70% -2.849	-6.431	-9.365	-4.974	-0.134
Income/Loss From Continuing Operations Before Tax	27.45% 39.34	30.86	47.68	50.24	47.88
Income Tax Expense/Benefit	48.92% 8.305	5.577	7.254	12.29	4.126
Income/Loss From Continuing Operations After Tax	22.72% 31.03	25.29	40.43	37.95	43.18
Net Income/Loss	22.72% 31.03	25.29	40.43	37.95	43.18
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.45% 46.95	47.64	48.62	48.91	48.21
Diluted Average Shares	3.53% 48.13	49.89	51.86	52.05	53.01
Basic Earnings Per Share	24.53% 0.66	0.53	0.83	0.77	0.90
Diluted Earnings Per Share	25.49% 0.64	0.51	0.78	0.73	0.81
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$29.94

3.53%

ELAN

$18.43

5.50%

RDY

$14.34

1.34%

VTRS

$10.50

1.65%

NBIX

$144.10

2.64%

UTHR

$400.52

5.27%